Production (Stage)
Gyre Therapeutics, Inc.
GYRE
$8.44
-$0.56-6.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 29.89M | 26.67M | 25.09M | 25.10M | 37.35M |
| Total Receivables | 22.52M | 29.15M | 20.77M | 19.91M | 16.75M |
| Inventory | 7.88M | 6.34M | 6.38M | 5.64M | 4.94M |
| Prepaid Expenses | 8.16M | 1.19M | 1.05M | 1.15M | 1.79M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.44M | 1.51M | 1.72M | 1.90M |
| Total Current Assets | 68.45M | 64.79M | 54.81M | 53.52M | 62.72M |
|
|
|||||
| Total Current Assets | 68.45M | 64.79M | 54.81M | 53.52M | 62.72M |
| Net Property, Plant & Equipment | 25.12M | 25.70M | 26.43M | 25.77M | 23.92M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.08M | 1.71M | 1.66M | 1.65M | 1.68M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.77M | 8.65M | 12.83M | 11.19M | 10.58M |
| Total Assets | 129.79M | 125.41M | 125.24M | 120.93M | 122.01M |
|
|
|||||
| Total Accounts Payable | 122.00K | 108.00K | 303.00K | 271.00K | 330.00K |
| Total Accrued Expenses | 9.58M | 9.30M | 8.16M | 9.12M | 9.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 805.00K | 713.00K | 694.00K | 659.00K | 100.00K |
| Total Finance Division Other Current Liabilities | 8.48M | 9.39M | 5.56M | 5.53M | 9.33M |
| Total Other Current Liabilities | 8.48M | 9.39M | 5.56M | 5.53M | 9.33M |
| Total Current Liabilities | 18.99M | 19.52M | 14.72M | 15.57M | 19.49M |
|
|
|||||
| Total Current Liabilities | 18.99M | 19.52M | 14.72M | 15.57M | 19.49M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 780.00K | 885.00K | 1.10M | 1.30M | 175.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.72M | 6.60M | 10.95M | 10.71M | 13.58M |
| Total Liabilities | 25.49M | 27.00M | 26.77M | 27.58M | 33.24M |
|
|
|||||
| Common Stock & APIC | 138.27M | 136.27M | 134.38M | 133.74M | 133.28M |
| Retained Earnings | -67.66M | -70.36M | -70.26M | -71.38M | -74.91M |
| Treasury Stock & Other | -2.49M | -2.60M | -946.00K | -2.01M | -1.74M |
| Total Common Equity | 68.12M | 63.32M | 63.18M | 60.35M | 56.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 68.12M | 63.32M | 63.18M | 60.35M | 56.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 36.18M | 35.08M | 35.30M | 33.00M | 32.13M |
| Total Equity | 104.30M | 98.40M | 98.47M | 93.35M | 88.77M |
|
|
|||||